CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Med, Dev Officer Dana Pizzuti sold $331K of Crinetics Pharmaceuticals, Inc.
Sold$331,284
$34.57Price
9,583Shares
−62%Stake
What CRNX did after the filing
- The stock from Fri, Dec 22 close, $35.91
- +5.2%
- S&P 500, same days
- +5.2%
Measured over 30 trading days, to the Feb 7 close.
Traded Thu, Dec 21. Filed Fri, Dec 22, 1:45 PM ET, during the session. Returns use the Dec 22 close and the Feb 7 close. Not investment advice.